|
시장보고서
상품코드
2120113
무증상 심근경색 시장 규모, 점유율, 성장 분석 : 진단별, 치료별, 리스크 그룹별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Silent Heart Attack Market Size, Share, and Growth Analysis, By Diagnosis (Electrocardiogram (ECG), Blood Tests), By Treatment, By Risk Group, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 무증상 심근경색 시장 규모는 2024년에 78억 3,000만 달러로 평가되며, 2025년 83억 7,000만 달러에서 2033년까지 142억 7,000만 달러로 확대될 전망이며, 예측 기간(2026-2033년) 동안 CAGR 6.9%로 성장할 것으로 전망됩니다.
무증상 심근경색 솔루션 시장은 기존의 흉통 증상을 동반하지 않는 경우가 많기 때문에 미진단된 심근경색을 대상으로 한 진단, 모니터링 기기 및 치료법을 포괄하고 있습니다. 심근경색의 상당 부분이 간과되고 있는 상황에서, 웨어러블 심전도 패치나 AI 위험도 평가 시스템과 같은 조기 개입 도구에 대한 수요가 급증하고 있으며, 이는 환자와 임상의 모두에게 비용 절감 가능성을 부각시키고 있습니다. 이러한 추세는 심혈관 건강 관리가 사후 대응형에서 예방형으로 전환되고 있음을 의미합니다. 예방 심장학에 대한 규제 당국의 지원이 성장의 주요 원동력이 되고 있습니다. 이는 조기 발견이 장기적인 의료 비용을 최소화한다는 점을 각국 정부가 인식하고 있기 때문입니다. 고감도 트로포닌 검사의 보험 적용 및 원격 모니터링 시스템 권장 등의 조치로 인해 제조사들은 생산을 확대하고 혁신에 대한 투자를 촉진하는 데 힘을 얻고 있으며, 이는 궁극적으로 환자의 예후를 개선하고 보험사의 관심도 끌고 있습니다.
세계 무증상 심근경색 시장의 성장요인
전 세계적으로 65세 이상 고령 인구가 증가함에 따라 무증상 심근 사건의 유병률이 현저히 높아지고 있습니다. 이러한 인구통계학적 추세로 인해 의료 종사자와 간병인들 사이에서 조기 발견 방법의 중요성에 대한 인식이 높아지고 있습니다. 그 결과, 혁신적인 무증상 심근경색 모니터링 기기, 예측 분석 및 예방 요법에 대한 수요가 증가하고 있습니다. 이러한 관심 증가는 제조사들이 혁신을 촉진하고 판매 네트워크를 확대하는 데 박차를 가하고 있으며, 이러한 첨단 도구가 임상 현장과 재택 간병 환경 모두에서 보급됨에 따라 시장 성장을 견인하고, 궁극적으로 환자의 예후를 개선하며 무증상 심근경색에 대한 전반적인 인식을 높이고 있습니다.
세계 무증상 심근경색 시장의 제약요인
무증상 심근경색 검출에 사용되는 기기는 그 복잡하고 정교한 특성으로 인해 의료 기관의 도입 및 유지 관리 비용이 고액인 경향이 있습니다. 특히 공공 자금으로 운영되거나 자원이 제한된 의료 기관의 경우, 예산 제약으로 인해 경영진은 고가의 전문 기술에 투자하기보다는 필수 서비스에 중점을 둘 수밖에 없습니다. 이러한 재정적 부담은 임상 현장에서의 신기기 도입을 방해하고, 환자의 접근성을 제한하며, 시장 전체의 성장을 둔화시키고 있습니다. 그 결과, 제조사들은 특히 신흥국에서 비용 대비 효과에 대한 명확한 증거나 이러한 혁신 기술에 대한 충분한 보험 급여 지원이 없는 한, 신속한 시장 침투를 달성하기 어려워지고 있습니다.
세계 무증상 심근경색 시장의 동향
세계 무증상 심근경색 시장은 조기 발견 검사 기법에 AI 기술을 통합하는 것을 원동력으로 삼아 큰 변화를 겪고 있습니다. 의료 서비스 제공자들은 웨어러블 센서 데이터를 분석하여 무증상 심근경색의 미묘한 징후를 식별하는 첨단 알고리즘을 도입하고 있습니다. 심박 변이도 및 미세혈관의 스트레스 지표를 지속적으로 모니터링함으로써, 이러한 AI 플랫폼은 실시간 위험 평가를 가능하게 하고 시기적절한 예방 의료를 촉진합니다. AI를 활용한 모니터링으로의 이러한 전환은 기존의 병원 방문 의존도를 최소화할 뿐만 아니라, 환자의 참여를 높이고 맞춤형 치료 접근법을 조성하는 데에도 기여합니다. 그 결과, AI는 무증상 심근경색 분야에서 조기 진단과 더 나은 건강 결과를 가져오는 매우 중요한 원동력으로 부상하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 무증상 심근경색 시장 규모 : 진단별
세계의 무증상 심근경색 시장 규모 : 치료별
세계의 무증상 심근경색 시장 규모 : 리스크 그룹별
세계의 무증상 심근경색 시장 규모 : 최종사용자별
세계의 무증상 심근경색 시장 규모 : 유통 채널별
세계의 무증상 심근경색 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.09.01Global Silent Heart Attack Market size was valued at USD 7.83 Billion in 2024 and is poised to grow from USD 8.37 Billion in 2025 to USD 14.27 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The market for silent heart attack solutions encompasses diagnostics, monitoring devices, and therapies aimed at undetected myocardial infarctions, which often lack traditional chest-pain symptoms. With a significant percentage of heart attacks remaining unnoticed, the demand for early intervention tools like wearable ECG patches and AI risk-scoring systems has surged, highlighting the cost-saving potential for both patients and clinicians. This trend signifies a transformation from reactive to proactive cardiovascular health management. Regulatory support for preventive cardiology is a key driver of growth, as governments acknowledge that early detection minimizes long-term healthcare costs. Initiatives, including reimbursement for high-sensitivity troponin assays and endorsement of remote monitoring systems, have encouraged manufacturers to enhance production and invest in innovation, ultimately improving patient outcomes and attracting insurers.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Silent Heart Attack market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Silent Heart Attack Market Segments Analysis
Global silent heart attack market is segmented by diagnosis, treatment, risk group, end user, distribution channel and region. Based on diagnosis, the market is segmented into Electrocardiogram (ECG), Blood Tests, Cardiac Imaging and Others. Based on treatment, the market is segmented into Medication, Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG). Based on risk group, the market is segmented into Diabetic Patients, Elderly Population, High Cardiovascular Risk Patients and Others. Based on end user, the market is segmented into Hospitals, Cardiology Clinics and Diagnostic Centers. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Silent Heart Attack Market
The growing global population of individuals aged sixty-five and older is leading to a notable increase in the prevalence of asymptomatic myocardial events. This demographic trend has heightened awareness among healthcare professionals and caregivers about the importance of early detection methods. Consequently, there is a rising demand for innovative silent heart attack monitoring devices, predictive analytics, and preventive therapies. This growing interest encourages manufacturers to foster innovation and expand their distribution networks, driving market growth as these advanced tools gain traction in both clinical and home-care environments, thereby enhancing patient outcomes and overall awareness of silent heart attacks.
Restraints in the Global Silent Heart Attack Market
The complex and advanced nature of equipment used for detecting silent heart attacks often leads to high acquisition and maintenance costs for healthcare facilities. Budget constraints, particularly in publicly funded and resource-limited institutions, force management to focus on essential services instead of investing in expensive specialized technologies. This financial strain hinders the adoption of new devices in clinical settings, restricts patient access, and diminishes overall market growth. As a result, manufacturers encounter difficulties in achieving quick market penetration, particularly in emerging economies, without clear evidence of cost-effectiveness or adequate reimbursement support for these innovations.
Market Trends of the Global Silent Heart Attack Market
The Global Silent Heart Attack market is experiencing a significant transformation driven by the integration of AI technology in early detection methodologies. Healthcare providers are adopting advanced algorithms that analyze wearable sensor data to identify subtle indicators of silent myocardial infarctions. By continuously monitoring heart rhythm variability and micro-vascular stress markers, these AI platforms facilitate real-time risk assessment, prompting timely preventive care. This shift towards AI-powered monitoring not only minimizes the dependence on traditional clinical visits but also enhances patient engagement and cultivates personalized treatment approaches. Consequently, AI emerges as a pivotal force for earlier diagnosis and better health outcomes in the silent heart attack landscape.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Silent Heart Attack Market Size by Diagnosis & CAGR (2026-2033)
- Market Overview
- Electrocardiogram (ECG)
- Blood Tests
- Cardiac Imaging
- Others
Global Silent Heart Attack Market Size by Treatment & CAGR (2026-2033)
- Market Overview
- Medication
- Percutaneous Coronary Intervention (PCI)
- Coronary Artery Bypass Grafting (CABG)
Global Silent Heart Attack Market Size by Risk Group & CAGR (2026-2033)
- Market Overview
- Diabetic Patients
- Elderly Population
- High Cardiovascular Risk Patients
- Others
Global Silent Heart Attack Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Cardiology Clinics
- Diagnostic Centers
Global Silent Heart Attack Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Silent Heart Attack Market Size & CAGR (2026-2033)
- North America (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
- US
- Canada
- Europe (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- GE HealthCare Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FUJIFILM Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Samsung Medison Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HeartFlow, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AliveCor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- iRhythm Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiac Insight, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
